Intractable diarrhea of infancy with facial dysmorphism, trichorrhexis nodosa, and cirrhosis

Maeran C Landers1, Theresa L Schroeder

  • 1Department of Dermatology, Oregon Health and Science University, Portland, Oregon 97201, USA. landersm@ohsu.edu

Pediatric Dermatology
|October 3, 2003
PubMed

Insights

A rare pediatric syndrome presents with intractable diarrhea, failure to thrive, and brittle hair (trichorrhexis nodosa). This condition also involves liver cirrhosis and developmental delays, requiring medical awareness.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Dermatology
  • Medical Genetics

Background:

  • Intractable infant diarrhea is a known gastroenterological entity.
  • Trichorrhexis nodosa, characterized by brittle hair, is a dermatological finding.
  • Syndromic presentations often involve multiple organ systems.

Observation:

  • A 3-year-old girl presented with severe intractable diarrhea, failure to thrive, and lifelong total parenteral nutrition (TPN).
  • Physical examination revealed facial dysmorphism, hepatomegaly, mental retardation, and developmental delay.
  • Microscopic examination of the hair confirmed trichorrhexis nodosa.

Findings:

  • The patient's clinical presentation included severe intractable diarrhea, trichorrhexis nodosa, and liver cirrhosis.
  • The constellation of symptoms suggests a potential link to the syndrome of intractable infant diarrhea.
  • This case highlights the dermatological manifestation of a complex pediatric syndrome.

Implications:

  • Dermatologists should consider trichorrhexis nodosa as a potential sign of underlying systemic syndromes.
  • Increased awareness of the syndrome of intractable infant diarrhea among dermatologists is warranted.
  • Further research may elucidate the genetic and pathophysiological basis of this rare condition.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...